ANNA CATHERINE BOUDREAUX: Open Payments
NPI 1184458846 · OXFORD, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$293 in 13 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $15 · 2025 $293
Food & beverage: $293
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 3 | $68 |
| Janssen Biotech, Inc. | 2 | $57 |
| VERTEX PHARMACEUTICALS INCORPORATED | 2 | $39 |
| UROGEN PHARMA, INC. | 1 | $31 |
| Antares Pharma, Inc. | 1 | $26 |
| IMMUNITYBIO, INC. | 1 | $20 |
| COLOPLAST CORP | 1 | $19 |
| Dendreon Pharmaceuticals LLC | 1 | $17 |
| Teleflex LLC | 1 | $16 |
Products named: ERLEADA, GEMTESA, JOURNAVX, XYOSTED, ANKTIVA, ORGOVYX, Titan, PROVENGE.
Industry payments across MS — which companies pay providers there.
